Serotonin dysfunction in autism spectrum disorder: A neurological perspective

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by impaired social interaction, communication difficulties, and repetitive behaviours. Emerging evidence suggests that serotonin (5-hydroxytryptamine, 5-HT) plays a pivotal role in ASD pathophysiology. Serotonin's widespread influence on neurodevelopmental processes, including neurogenesis, synaptogenesis, and neural circuit formation, underscores its significance in ASD research. Hyperserotonemia, a condition marked by elevated blood serotonin levels, has been identified as the first biomarker of ASD, affecting approximately 30% of individuals with the disorder. Genetic studies implicate serotonin transporter (SERT) gene variations, such as the Ala56 variant, in ASD-associated behaviouralabnormalities. Functional imaging and biochemical studies reveal disruptions in serotonin synthesis, receptor binding, and transporter activity in autistic individuals.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-15
DOI
https://doi.org/10.5281/zenodo.14874331
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serotonin dysfunction in autism spectrum disorder: A neurological perspective

Zenodo (CERN European Organization for Nuclear Research)
Autism Spectrum Disorder Research
article

Serotonin dysfunction in autism spectrum disorder: A neurological perspective

article en

Abstract

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by impaired social interaction, communication difficulties, and repetitive behaviours. Emerging evidence suggests that serotonin (5-hydroxytryptamine, 5-HT) plays a pivotal role in ASD pathophysiology. Serotonin's widespread influence on neurodevelopmental processes, including neurogenesis, synaptogenesis, and neural circuit formation, underscores its significance in ASD research. Hyperserotonemia, a condition marked by elevated blood serotonin levels, has been identified as the first biomarker of ASD, affecting approximately 30% of individuals with the disorder. Genetic studies implicate serotonin transporter (SERT) gene variations, such as the Ala56 variant, in ASD-associated behaviouralabnormalities. Functional imaging and biochemical studies reveal disruptions in serotonin synthesis, receptor binding, and transporter activity in autistic individuals.

Zenodo (CERN European Organization for Nuclear Research)
Reduced inequalities
Openalex Percentile: Top 50%
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serotonin dysfunction in autism spectrum disorder: A neurological perspective · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS